Concentrix Scholarship Programme

Concentrix Scholarship Programme

👁 145 views
Scholarship
15 Oct 2026 - 31 Oct 2026

Event Information

The Concentrix Scholarship Program 2026-27 supports Pan-India female students in the first year of an MBBS program at government medical colleges, offering financial assistance of up to INR 65,000 per year to ease the cost of medical education and enable them to complete their course.

About the Scholarship

  • Prizes & Rewards: Scholarship of up to INR 65,000 per year covering institution fees, examination fees, books, stationery, equipment, and other academic costs.
  • Last Date to Apply: 30-10-2026
  • Application mode: Online Application Only

Eligibility:

  • Open to Pan India female students currently enrolled in the first year of an MBBS program at a government medical college.
  • Applicants must have successfully completed their Grade 12 board examination.
  • The annual parental income of the applicant must not exceed INR 5 lakh from all sources.
Stay Connected with Campuzine!

Campuzine Scholars Edu Hub LLP is an initiative dedicated to bridging the gap between Higher Education Institutions (HEIs) across India. We provide a platform for students, educators, and institutions to connect, share information, exchange ideas, and build a collaborative academic community that encourages innovation, knowledge sharing, and transformative thinking.Campuzine Scholars Edu Hub LLP connects students, educators, and higher education institutions across India through academic collaboration and knowledge sharing.

Follow our WhatsApp Channel for the latest academic and campus event updates.
💬 Follow on WhatsApp

Organising an Event? Create an account on Campuzine and share your institution’s events through our platform to reach a wider audience.

Explore membership options for Scholars, Educators, Institutions, and Associates.
Explore Membership →

Connect • Collaborate • Share • Grow
Ready to register?
Seats may be limited, register now or check the event details.

Comments (0)

No comments yet. Be the first to share your thoughts.

Log in to join the discussion
Log in Register free
Link copied to clipboard!